Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

36
SummaryQuotesNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Allergan : Schedules Second Quarter 2015 Earnings Conference Call and Webcast

07/03/2015 | 03:15am US/Eastern

Allergan plc reported that it intends to release second quarter 2015 financial results on Thursday, August 6, prior to the open of the U.S. financial markets.

The Company will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on Thursday, August 6, to discuss its financial results. The dial-in number to access the call is U.S./ Canada (877) 251-7980, International (706) 643-1573, and the Passcode is 73405830.

According to a release from the Company, a taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 11:30 PM Eastern Time on August 20. The replay may be accessed by dialing (855) 859-2056 and entering Passcode # 29079446. From international locations, the replay may be accessed by dialing (404) 537-3406 and entering the same Passcode. To access the webcast, go to Allergan's Investor Relations Web site at http:// ir.allergan.com. A replay of the webcast will also be available.

Allergan, headquartered in Dublin, Ireland, is a global pharmaceutical company.

More Information:

http://www.allergan.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))

(c) 2015 ProQuest Information and Learning Company; All Rights Reserved., source Trade Publications

React to this article
Latest news on ALLERGAN, INC.
07/03 ALLERGAN : Schedules Second Quarter 2015 Earnings Conference Call and Webcast
07/02 ALLERGAN : Entry into a Material Definitive Agreement, Financial Statements and ..
07/01 KYTHERA BIOPHARMACEUTICALS : KYTH INVESTOR ALERT: The Law Offices of Vincent Won..
06/29 KYTHERA BIOPHARMACEUTICALS : NASDAQ:KYTH) Shareholder Notice: Investigation of T..
06/28 ALLERGAN : Selects Richmond Plastic Surgeon to Exclusively Offer Newly Released ..
06/26 ALLERGAN : Selects Richmond Plastic Surgeon to Exclusively Offer Newly Released ..
06/25 CANADA'S VALEANT APPROACHES TO BUY Z : Wsj
06/24 ALLERGAN : Recent FDA Approval of New Breast Implant Highlights the Ongoing Dema..
06/24 KYTHERA BIOPHARMACEUTICALS : Law Firm Kirby McInerney LLP Investigating Potentia..
06/24 KYTHERA BIOPHARMACEUTICALS : ALERT: Johnson & Weaver, LLP Investigates the Fairn..
Advertisement
Income Statement Evolution
More Financials